ArticleThe Journal of clinical endocrinology and metabolism2026
Safety and effectiveness of rivaroxaban thromboprophylaxis in adrenocorticotropic hormone-dependent Cushing syndrome.
Zin Htut et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.